Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A randomized, double-blinded, phase III trial aimed to study treating Urinary Tract Infections (UTI)
Primary outcome measures:
Percentage of Patients With Composite of Microbiological Eradication and Clinical Cure in the Microbiological Modified ITT (mMITT) Population
The authors concluded that once-daily plazomicin was non-inferior to meropenem for treating complicated Urinary Tract Infections (UTI) and acute pyelonephritis caused by Enterobacteriaceae, including multidrug-resistant strains.
…